1.5心室修复术:限制前向肺血流的潜在作用
该回顾性研究纳入1989至2020年接受1.5心室修复的74例患者,中位随访39.9个月,10年无移植生存率92.4%。
要点
- 1.5心室修复后10年无移植生存率92.4%,但上腔静脉高压发生率达39%。
- 右房高压在隔板与未隔板组间无差异。
核心结论
- 1.5心室修复可避免Fontan相关并发症且无移植生存率良好,但上腔静脉高压仍是显著远期并发症。
- 1.5心室修复时行肺动脉隔板术可能降低上腔静脉高压风险。
研究设计与样本
- 回顾性研究,纳入1989至2020年接受1.5心室修复的74例患者,中位手术年龄29.6个月(IQR 8.9–45.5个月),中位随访39.9个月(IQR 11.4–178.1个月)。
主要发现
- 10年无移植生存率为92.4%。
- 存活者中12%(8/69)出现右房高压,39%(27/69)出现上腔静脉高压。
- 两组右房高压无差异。
关键数值与推荐
- 上腔静脉高压定义:平均Glenn压力>17 mm Hg、上腔静脉血流反向或搏动、静脉-静脉侧支血管或上腔静脉综合征。
- 右房高压定义:平均右房压>10 mm Hg伴下腔静脉和肝静脉扩张或血流反向。
临床怎么用
- 对低肺动脉心室发育不良患者,1.5心室修复可作为Fontan替代方案,但需长期监测上腔静脉高压。
- 在1.5心室修复时考虑行肺动脉隔板术以降低上腔静脉高压风险。
局限性
- 回顾性研究,样本量74例,单中心经验,随访时间跨度大,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with hypoplastic subpulmonary ventricles, the one and one-half ventricle (1.5V) repair is an alternative to the Fontan procedure. However, in 1.5V-treated patients with pulsatile pulmonary blood flow, superior vena cava (SVC) hypertension or right atrial hypertension may develop. This study aimed to (1) describe patient outcomes after 1.5V repair and (2) determine whether pulmonary artery septation at 1.5V repair confers a lower risk of SVC or right atrial hypertension. METHODS: This study retrospectively reviewed patients who underwent a 1.5V repair between 1989 and 2020. The primary outcome was transplant-free survival. Secondary outcomes were postoperative SVC hypertension (defined by mean Glenn pressures greater than 17 mm Hg, SVC flow reversal or pulsatility, venovenous collateral vessels, or SVC syndrome) and right atrial hypertension (defined as mean right atrial pressures greater than 10 mm Hg with inferior vena cava and hepatic vein dilation or flow reversal). RESULTS: A total of 74 patients underwent 1.5V repair at a median age of 29.6 months (interquartile range, 8.9 to 45.5 months). Median follow-up time was 39.9 months (interquartile range, 11.4 to 178.1 months). Transplant-free survival at 10 years was 92.4%. Among survivors, 12% (8 of 69) had right atrial hypertension and 39% (27 of 69) had SVC hypertension on follow-up. Survivors with unseptated pulmonary arteries had a greater risk of SVC hypertension compared with patients with septated pulmonary arteries (44% vs 10%; P = .04). No difference was found in right atrial hypertension between the 2 groups. CONCLUSIONS: Patients with 1.5V repair avoid Fontan-associated complications with favorable transplant-free survival. However, SVC hypertension remains a significant long-term complication. Pulmonary artery septation at 1.5V repair may reduce the risk of SVC hypertension.
引用
- Prasanna A, Tan CW, Anastasopulos A, et al. One and One-Half Ventricle Repair: Role for Restricting Antegrade Pulmonary Blood Flow. Ann Thorac Surg. 2021. PMID: 33964261. doi:10.1016/j.athoracsur.2021.04.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。